Delivery Order SPE2DB22D2005-SPE2DB25FJMJ9
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,625.87 firm fixed-price delivery order is for the supply of MS Contin ER 30 mg tablets, a pain management medication. The contract has an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,715.90 firm fixed-price delivery order is for the supply of MS CONTIN ER 15 MG TABLET 100S, a pain management medication. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV7EJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,715.55 firm fixed-price delivery order is for the pharmaceutical product MS CONTIN ER 15 MG TABLET 100S. The contract has an ultimate completion date of December 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of MS CONTIN ER 15 MG TABLET 100S, a prescription medication. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 25, 2025, with a ceiling value of $1,566.37 and an ultimate completion date of March 26, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,030.63, is a delivery order for the supply of MS CONTIN ER 15 MG TABLET 100S, a pain medication. The contract has an ultimate completion date of March 26, 2025 and a firm fixed price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,271.20, is for the supply of MS CONTIN ER 15 MG TABLET 100S, a prescription medication. The contract has a period of performance through January 29, 2025 and is a firm fixed-price type. This order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support...
This federal contract award, valued at $1,629.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, is for the supply of MS CONTIN ER 15 MG TABLET 100S, a pharmaceutical product. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite...
This federal contract award, valued at $1,204.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MS CONTIN ER 30 MG TABLET 100S, a prescription pain medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, designated as SPE2DX, which has a ceiling value of $999,999,999.00. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,266.82 for the supply of 4568013007 - Morphine Sulf ER 15 mg Tablet UD 100s. The award has an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,005.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,183,266 units of Morphine Sulfate Extended-Release 15 mg tablets and has a completion date of April 17, 2025. The contract is a firm-fixed-price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...